文献
J-GLOBAL ID:201702223204579251
整理番号:17A1428338
クリゾチニブ耐性ALK陽性非小細胞肺癌における中枢神経系転移におけるアレクチニブの有効性:RECIST1.1とRANO HGG基準の比較【Powered by NICT】
Efficacy of alectinib in central nervous system metastases in crizotinib-resistant ALK-positive non-small-cell lung cancer: Comparison of RECIST 1.1 and RANO-HGG criteria
著者 (18件):
Gandhi Leena
(Department of Medicine, New York University, Perlmutter Cancer Center, NYU School of Medicine, New York, USA)
,
Ou Sai-Hong Ignatius
(Department of Medicine, Chao Family Comprehensive Cancer Center, University of California Irvine School of Medicine, Orange, CA, USA)
,
Shaw Alice T.
(Department of Thoracic Oncology, Massachusetts General Hospital, Boston, MA, USA)
,
Barlesi Fabrice
(Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, Assistance Publique Hopitaux de Marseille, Marseille, France)
,
Dingemans Anne-Marie C.
(Department of Respiratory Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands)
,
Kim Dong-Wan
(Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea)
,
Camidge D. Ross
(Department of Medicine, University of Colorado Cancer Center, Denver, CO, USA)
,
Hughes Brett G.M.
(Department of Oncology, The Prince Charles Hospital, and School of Medicine, University of Queensland, Queensland, Australia)
,
Yang James C.-H.
(Department of Oncology, National Taiwan University Hospital and National Taiwan University Cancer Center, Taipei, Taiwan)
,
de Castro Javier
(Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain)
,
Crino Lucio
(Department of Oncology, Istituto Scientifico Romagnolo per lo studio e la Ricerca dei tumori, IRCCS, Meldola, Italy)
,
Lena Herve
(Pulmonology Department, Centre Hospitalier Universitaire de Rennes, Rennes, France)
,
Do Pascal
(Medical Thoracic Oncology, Centre Francois Baclesse, Caen, France)
,
Golding Sophie
(Biostatistics Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland)
,
Bordogna Walter
(Product Development Oncology, F. Hoffmann-La Roche Ltd, Basel, Switzerland)
,
Zeaiter Ali
(Pharmaceutical Division, F. Hoffmann-La Roche Ltd, Basel, Switzerland)
,
Kotb Ahmed
(Global Medical Affairs (Oncology), F. Hoffmann-La Roche Ltd, Basel, Switzerland)
,
Gadgeel Shirish
(Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
82
ページ:
27-33
発行年:
2017年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)